Crown ElectroKinetics organizacji EBITDA margin
Jaka jest wartość EBITDA margin organizacji Crown ElectroKinetics?
Wartość EBITDA margin organizacji Crown ElectroKinetics Corp. to -329.17%
Jaka jest definicja EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin firm w Materials sektor na OTC w porównaniu do Crown ElectroKinetics
Czym się zajmuję organizacja Crown ElectroKinetics?
Crown Electrokinetics Corp. develops and sells optical switching films. The company also focuses on commercializing electrokinetic technology for use in the smart glass market. It offers electrokinetic film technology for smart or dynamic glass. The company was formerly known as 3D Nanocolor Corp. and changed its name to Crown ElectroKinetics Corp. in October 2017. Crown ElectroKinetics Corp. was incorporated in 2015 and is based in Corvallis, Oregon.
Firmy z ebitda margin podobne do Crown ElectroKinetics
- Wartość EBITDA margin organizacji Microba Life Sciences Ltd to -331.80%
- Wartość EBITDA margin organizacji Global Blood Therapeutics to -330.50%
- Wartość EBITDA margin organizacji Sienna Cancer Diagnostics to -330.16%
- Wartość EBITDA margin organizacji Nova Royalty to -330.11%
- Wartość EBITDA margin organizacji Vermillion to -329.33%
- Wartość EBITDA margin organizacji Clearside Biomedical Inc to -329.31%
- Wartość EBITDA margin organizacji Crown ElectroKinetics to -329.17%
- Wartość EBITDA margin organizacji Hexagon Materials to -328.63%
- Wartość EBITDA margin organizacji Fitch Street Capital to -328.52%
- Wartość EBITDA margin organizacji Cauldron to -327.95%
- Wartość EBITDA margin organizacji Killi to -327.51%
- Wartość EBITDA margin organizacji Sesen Bio to -326.20%
- Wartość EBITDA margin organizacji EastWest Bioscience to -324.91%